Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy
Sponsor: The University of Texas Health Science Center at San Antonio
Listed as NCT03064568, this PHASE4 trial focuses on Myomectomy; Surgical Blood Loss and remains completed. Sponsored by The University of Texas Health Science Center at San Antonio, it has been updated 13 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Aug 2025 — Present [monthly]
Completed PHASE4
-
Jan 2025 — Aug 2025 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Sep 2024 — Jan 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Oct 2023 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 8 earlier versions
-
Sep 2022 — Oct 2023 [monthly]
Recruiting PHASE4
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Aug 2019 — Sep 2020 [monthly]
Recruiting PHASE4
-
Dec 2018 — Aug 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Dec 2018 [monthly]
Recruiting PHASE4
-
Mar 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The University of Texas Health Science Center at San Antonio
For direct contact, visit the study record on ClinicalTrials.gov .